← back to search

Haobin Hu

Guangzhou University of Chinese Medicine · CN
Area of research
Molecular Biology · Plant Science
Research interest
Research interests include Photocatalysis, Materials science, Delocalized electron, Heterojunction, X-ray photoelectron spectroscopy, and Water splitting.
h-index
citations
291
works
4
NIH funding
primary concept
email

Recent publications

Interface-induced charge transfer pathway switching of a Cu2O-TiO2 photocatalyst from p-n to S-scheme heterojunction for effective photocatalytic H2 evolution
Journal of Material Science and Technology 2024cited by 149position: middledoi
Regulating local polarization in truxenone-based covalent organic frameworks for boosting photocatalytic hydrogen evolution
Science China Materials 2024cited by 79position: middledoi
Topology-induced local electric polarization in 2D thiophene-based covalent organic frameworks for boosting photocatalytic H2 evolution
CHINESE JOURNAL OF CATALYSIS (CHINESE VERSION) 2024cited by 60position: middledoi
Misdiagnosis of lymphoma as vasculitis: A case report
Respirology Case Reports 2024cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guijie Liang · Hubei University of Arts and Science3 papers (2024–2024)Xin Li · Shandong University3 papers (2024–2024)Rongchen Shen · South China Agricultural University3 papers (2024–2024)Chaochao Qin · Henan Normal University2 papers (2024–2024)Neng Li · Guangzhou University of Chinese Medicine1 papers (2024–2024)Shaolong Sun · South China Agricultural University1 papers (2024–2024)Lei Hao · South China Agricultural University1 papers (2024–2024)Qingling Zhang · Guangzhou University of Chinese Medicine1 papers (2024–2024)Kaihui Huang · South China Agricultural University1 papers (2024–2024)Xiaoming Peng · University of Wollongong1 papers (2024–2024)Difa Xu · Hunan University1 papers (2024–2024) · 1 papers (2024–2024)Shushan Wei · Guangzhou Medical University1 papers (2024–2024)Junxian Bai · South China Agricultural University1 papers (2024–2024)